Critical
[대역어] 흠을 잘 잡는
[용어속성] Term
[용어속성] Term
MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies
MiRNA-SARS-CoV-2 대화 및 전향적인 항-COVID-19 치료법
Review
Published on
Journal: Life sciences [Category] COVID19(2023년), MERS, SARS, 바이오마커, 변종, 비임상, 진단, 치료기술, 치료제,
Journal: Life sciences [Category] COVID19(2023년), MERS, SARS, 바이오마커, 변종, 비임상, 진단, 치료기술, 치료제,
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus-2
adverse effect
adverse effects
Affect
antiviral response
approach
approved
Biomarker
caused
Cell signaling
chance
Clinical significance
Comorbidities
coronavirus
Coronavirus-2
country
COVID-19
COVID-19 illness
COVID-19 infection
COVID-19 pathogenesis
COVID-19 patient
Critical
death
detect
differential expression
disease
disease onset
disease pathology
effort
etiology
expression
FDA
focus
Host
host cell
host inflammatory response
host miRNA
host miRNAs
identify
Infection
life cycle
microRNA
miRNA
miRNAs
molecular interaction
non-coding RNA
offer
pathogen
Pathogen-host interaction
patients with COVID-19
post-transcriptionally
quest
reduce
respiratory
respond
RNA
RNA silencing
SARS Coronavirus
SARS coronavirus 2
SARS coronavirus 2.
SARS-CoV-2
SARS-CoV-2 variant
SARS-CoV-2 variants
SARS-CoV-2 virus
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
severity
Signaling
target gene
the SARS-CoV-2 virus
therapy
treat
Treatment
Viral
viral miRNA
viral miRNAs
[DOI] 10.1016/j.lfs.2022.120761 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.lfs.2022.120761 PMC 바로가기 [Article Type] Review
Robust and efficient COVID-19 detection techniques: A machine learning approach
Article
[키워드] Accuracy
approach
classical
Confusion
COVID-19
Critical
dataset
death
drug
Evidence
experimental evidence
gene cluster
Genetic
help
identify
include
infection rate
microRNA
miRNAs
pandemic
pre-miRNAs
Protein
random
reducing
respiratory
responsible
RNA
RNAs
SARS-CoV-2
SARS-CoV-2 genome
sequence
similarity
target region
the SARS-CoV-2 genome
the SARS-CoV-2 virus
Transmission
virus
Virus life cycle
[DOI] 10.1371/journal.pone.0274538 PMC 바로가기
[DOI] 10.1371/journal.pone.0274538 PMC 바로가기
SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns
Article
[키워드] antibody
antigenic
BA.2.12.1
BA.4
BA.5
convalescent
COVID-19
Critical
effective strategy
favor
identify
immune
Immune escape
inactive
monoclonal antibody
MOST
Neutralizing
Neutralizing antibodies
neutralizing antibody
omicron
polyclonal
predominant
provide
reduction in
resistance
SARS-CoV-2
sensitivity
sera
serum
sublineages.
susceptibility
Treatment
vaccinated individual
vaccinee
variants
viral evolution
[DOI] 10.1016/j.chom.2022.07.002 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.chom.2022.07.002 PMC 바로가기 [Article Type] Article
Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes
Article
[키워드] abundance
acute phase
acute respiratory syndrome
Alter
Analysis
approach
assays
body mass index
C-reactive protein
circulating
clinical decision
Compromised
coronavirus
COVID-19
COVID-19 pathogenesis
COVID-19 patient
creatinine
criterion
Critical
Critically ill
cut-off value
determine
disease
disrupt
driven by
dysregulation
energy-related metabolites
evaluated
Extracellular
fluorometric quantification
Glucose
Health
Host
Host immune response
immune response
implicated
IMPROVE
Increased
independent predictor
Infection
Lactate
mechanisms
metabolism
metabolite
metabolomics
mitochondrial
outcome
outcomes
Patient
Potential biomarker
Prognosis
Prognostic marker
provided
pyruvate
quantification
Quantitative
recruited
risk
SARS-CoV-2
SARS-COV-2 infection
semi-targeted metebolomics.
serum
severe COVID-19 illness
severity
Signaling
Stratification
Support
validation cohort
virus
[DOI] 10.3389/fimmu.2022.912579 PMC 바로가기
[DOI] 10.3389/fimmu.2022.912579 PMC 바로가기
SARS-CoV-2 Infection and Pregnancy: Maternal and Neonatal Outcomes and Placental Pathology Correlations
Article
[키워드] accumulating
amniotic
Analysis
anti-SARS-CoV-2
Autopsy
available data
Blood
Care
clinical
Clinical characteristics
Clinical management
correlation
Course
COVID-19
Critical
demise
elevated
Evidence
fetal
Hospital stay
IgM antibody levels
IHC
immunoexpression
immunohistochemistry
implication
Infant
Infants
Infection
initial
Laboratory results
Maternal
maternal and neonatal outcome
Nasopharyngeal swab
Neonatal
outcome
pathological finding
pathology
patients
Placenta
placental
Placental infection
placental pathology
positive
Positive test
Pregnancy
pregnant women
risk
RT-PCR
RT-PCR testing
SARS-CoV-2
SARS-CoV-2 antibody
SARS-CoV-2 genome
SARS-CoV-2-positive patients
SARS-CoV-2-specific IgG
selected
serum
significantly
study group
Surveillance
Transmission
umbilical cord blood
vertical transmission
was performed
women
[DOI] 10.3390/v14092043 PMC 바로가기
[DOI] 10.3390/v14092043 PMC 바로가기
Photochemical Identification of Auxiliary Severe Acute Respiratory Syndrome Coronavirus 2 Host Entry Factors Using μMap
Article
[키워드] ACE2
ACE2 expression
acute respiratory syndrome
auxiliary
cell entry
complex
coronavirus
coronavirus 2
COVID-19 pandemic
Critical
Delta
eight
engage
ENhance
enzyme
expression
facilitate
Factor
Genetic
Host
human cell
identification
identify
identifying
labeling
lymphocyte
membrane fusion
pathophysiology
platform
powerful tool
Protein
receptor
receptors
respiratory
SARS-CoV-2
significantly
spike variant
systemically
the spike protein
tissues
transmembrane serine protease
viral entry
Wuhan
[DOI] 10.1021/jacs.2c06806 PMC 바로가기
[DOI] 10.1021/jacs.2c06806 PMC 바로가기
Targeting Doublecortin-Like Kinase 1 (DCLK1)-Regulated SARS-CoV-2 Pathogenesis in COVID-19
Article
[키워드] Activation
amplified
amplify
analyzed
blocked
Blood
Cell
chemokine
chronic liver disease
Chronic Liver Diseases
circulating
comorbid disease
Comorbidity
contribute
controls
correlated
COVID-19
COVID-19 patients
Critical
cytokine
cytokine secretion
DCLK1
DDCLK1
decrease
disease severity
dysregulation
expression
Factor
Factors
Gain
growth factor
hospitalized patient
Host
Hyperinflammatory response
immune
Immune cell
immune response
immunosuppressive
in viral
in vitro
infected cells
Inflammation
Inflammatory cytokine
inflammatory pathway
inhibition
inhibitor
Innate immunity
involved
kinase
Live virus
liver
livers
loss of function
lung
Lung disease
Macrophage
mononuclear cell
mononuclear cells
Mortality
neutrophil
normalized
Pathogenesis
pathology
Patient
Peripheral blood
potential therapeutic target
Prevalence
pro-inflammatory
profile
proinflammatory
promoted
promoter
Protein
S100A9
SARS-CoV-2
SARS-CoV-2-infected cell
secretion
severity of COVID-19
Signaling
subject
targeting
Treatment
Viremia
virus production
virus replication
with COVID-19
β-catenin
[DOI] 10.1128/jvi.00967-22 PMC 바로가기
[DOI] 10.1128/jvi.00967-22 PMC 바로가기
Enhancing the Immunogenicity of RBD Protein Variants through Amino Acid E484 Mutation in SARS-CoV-2
Article
[키워드] acid
Antibody detection
Antibody testing
antigenic
COVID-19
COVID-19 pandemic
Critical
E. coli
E484K
effective
Effectiveness
Enhancing
Escherichia coli
Evolution of SARS-CoV-2
expressed
expression
immunogenicity
in vitro
mice
mutant
mutants
Neutralizing antibodies
nine
Protein
raise
RBD
RBD protein
recombinant RBD protein
SARS-CoV-2
SARS-CoV-2 RBD protein
single-point mutants
the RBD protein
vaccination
Vaccine
Vaccines
variants
western blotting
wild type
[DOI] 10.3390/v14092020 PMC 바로가기
[DOI] 10.3390/v14092020 PMC 바로가기
Contribution of Coronavirus-Specific Immunoglobulin G Responses to Complement Overactivation in Patients with Severe Coronavirus Disease 2019
Article
[키워드] Activation
acute respiratory syndrome
addition
Analysis
and antibodies
antibody
C1q
circulating
classical
classical pathway
common cold
common cold coronavirus
common cold Coronaviruses
complement
complement system
coronavirus
coronavirus disease
correlated
COVID-19
Critical
demonstrated
develop
disease
disease severity
greater
healthy control
hospitalized patient
IgG response
immune complex
Immunoglobulin
Immunoglobulin G
implicated
mechanism
moderate
modify
outcome
overactivation
Pathogenesis
Patient
patients with COVID-19
plasma
response
responsible
RNA
SARS-CoV-2
severe COVID-19
severe patients
severity
systemically
therapeutic strategy
with COVID-19
[DOI] 10.1093/infdis/jiac091 PMC 바로가기
[DOI] 10.1093/infdis/jiac091 PMC 바로가기